Kotak Private Equity, the alternative asset investment arm of India’s fourth-largest private lender Kotak Mahindra Bank, has picked a stake in a pharmaceuticals company that manufactures and markets formulations and active pharmaceutical ingredients (APIs) in India.The India Whizdom Fund, which started investing in last April, has picked a small stake, ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.